Monday, March 02, 2015 4:48:39 PM
http://finance.yahoo.com/news/intrexon-announces-fourth-quarter-full-210500595.html
"Looking ahead, we are very excited about our near term prospects and have much higher goals for 2015. In Health, we expect to see new major alliances formed, while we believe that our existing ECC partners will be in the clinic with up to ten novel therapeutic candidates. In Food, we anticipate continued growth of our base business with projected product and service revenues exceeding $100M," said CEO Randal Kirk of the company's prospects in 2015.
I Love you cause you Hate me
Recent PGEN News
- Precigen to Present Late-breaking Abstract for Pivotal Phase 2 Study Data for PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Patients with Recurrent Respiratory Papillomatosis at the 2024 ASCO Annual Meeting • PR Newswire (US) • 04/24/2024 02:20:00 PM
- Actym Therapeutics Appoints Thomas Smart as CEO • PR Newswire (US) • 04/24/2024 01:00:00 PM
- Precigen and Recurrent Respiratory Papillomatosis Foundation to Hold Inaugural International RRP Awareness Day on June 11th • PR Newswire (US) • 03/28/2024 08:05:00 PM
- Precigen Reports Full Year 2023 Financial Results and Business Updates • PR Newswire (US) • 03/19/2024 08:05:00 PM
- US Index Futures Decline Ahead of Federal Reserve Meeting, Oil Prices Retreat • IH Market News • 03/19/2024 11:27:29 AM
- Precigen to Participate in a Fireside Chat Hosted by Cantor Fitzgerald to Discuss PRGN-2012 AdenoVerse Immunotherapy for the Treatment of Recurrent Respiratory Papillomatosis • PR Newswire (US) • 03/12/2024 08:05:00 PM
- Precigen to Announce Fourth Quarter and Full Year 2023 Financial Results on March 19th • PR Newswire (US) • 03/05/2024 09:05:00 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/27/2024 06:48:40 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 02/14/2024 09:00:22 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/14/2024 08:20:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/08/2024 09:25:09 PM
- Precigen to Participate in the Oppenheimer 34th Annual Healthcare Life Sciences Conference • PR Newswire (US) • 02/06/2024 09:05:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 01/18/2024 05:15:14 AM
- Precigen Receives Orphan Drug Designation for PRGN-2012 for the Treatment of Recurrent Respiratory Papillomatosis from the European Commission • PR Newswire (US) • 01/16/2024 01:05:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 01:39:30 PM
- Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 01/08/2024 01:30:00 PM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 12/29/2023 10:26:37 PM
- Precigen to Present at the 42nd Annual J.P. Morgan Healthcare Conference • PR Newswire (US) • 12/18/2023 09:05:00 PM
- Precigen to Participate in the JMP Securities Hematology and Oncology Summit • PR Newswire (US) • 11/29/2023 09:05:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/09/2023 10:08:34 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/09/2023 10:07:37 PM
- Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs • PR Newswire (US) • 11/09/2023 09:55:00 PM
- Precigen to Participate in the Stifel 2023 Healthcare Conference • PR Newswire (US) • 11/07/2023 09:05:00 PM
- Precigen to Participate in Upcoming Leading Investor and Industry Conferences • PR Newswire (US) • 09/19/2023 08:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/25/2023 11:04:24 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM